Clinical Trials Browser

Phase EARLY_PHASE1 × Unknown × Epstein-Barr Virus Infections × Clear all

NCT04690036 2021-06-29

PD-1 Antibody for Reactive EBV After BMT

Phase EARLY_PHASE1 Unknown

Epstein-Barr Virus Infections